The Clinical Trials Division (CTD) is a vital part of the search for treatments for Alzheimer’s disease. The CTD is the pre-eminent site for trials into potential treatments for Alzheimer’s disease in Western Australia and conducts trials evaluating the effectiveness of pharmaceutical agents being investigated as therapeutic agents for Alzheimer’s disease.
The unit is supervised by Associate Prof Roger Clarnette, a senior specialist physician at Fremantle Hospital and Hollywood Private Hospital. As well as specialist medical qualifications Dr Clarnette has a PhD and particular interest in memory loss and Alzheimer’s disease.
Based at the Hollywood Specialist Centre, the unit is staffed by study coordinators with nursing qualifications, sessional clinical psychologists and medical practitioners.
Clinical trials are conducted under the ethical codes of both the Foundation and Hollywood Private Hospital and are in accord with strict national and international standards.
The trials we undertake are part of an international network testing the potential of drugs as treatments for Alzheimer’s disease.